Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Genentech files IND for basal cell carcinoma drug candidate

April 6, 2005

Hollis-Eden initiates phase I study for Neumune

April 6, 2005

Oncotherapy Science to begin clinical trial for OTS-102

April 6, 2005

Update: Cancer treatment with Gendicine, the first approved gene therapy

April 6, 2005

Tie-2 inhibitor with good in vivo profile effective in a murine model of angiogenesis

April 6, 2005

Antiangiogenic actions of oral lenalidomide in rats

April 5, 2005

ExCel study to investigate ability of exemestane to prevent breast cancer

April 4, 2005

New patents disclose therapeutic agents for cancer

April 4, 2005

Xeloda approved in E.U. as adjuvant therapy for colon cancer

April 1, 2005

Vion initiates phase III study of Cloretazine in relapsed AML

April 1, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...